Fig. 2: ROS1 and MET protein expression during the treatment course.

A Representative immunohistochemistry (IHC) images demonstrating the H&E, ROS1, and c-MET immunostaining at indicated time points. Scale bar: 100 µm. B Percentage of tumor cells immunostaining positive for ROS1 at same time points as shown in (A).